These include nausea (affecting 15-44% of users depending on dose), diarrhea (10-30%), vomiting (7-25%), constipation (6-24%), and abdominal pain or discomfort (approximately 9%)
The advantage of GLOW is that it reduces the likelihood that recovery stalls at any single point
What makes Stallion different from other telehealth providers
doi: 10.3389/fpls.2024.1349573 Received 04 December 2023 Accepted 17 April 2024 Published 21 May 2024 Volume 15 - 2024 Edited by Mohammad Mukarram, Universidad de la Repblica, Uruguay Reviewed by Radwan Khalil, Benha University, Egypt Baris Uzilday, Ege University, Trkiye Giuseppe Mannino, University of Turin, Italy Updates Copyright 2024 Tritean, Tric, Dima, Capr, Gabor, Cimpean, Oancea and Constantinescu-Aruxandei